Open house Arzneimittelrabattverträge zum Wirkstoff Evolocumab, ATC C10AX13

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - The health insurance fund offers rebate contracts with the above-mentioned active ingredient to all interested pharmaceutical companies without a selection decision. Contracts are concluded within the framework of an "open house model." The offered contracts are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The health insurance fund. In the open house model, uniform conditions apply to all participants. Contract contents, conditions, and access procedures are uniform – individual negotiations are not conducted. Contract durations are a maximum of 24 months, with the earliest contract start date being 01.09.2026. All contracts end at the latest 24 months after the earliest contract start date, regardless of the date of the respective contract conclusion. Joining or concluding a contract can occur within the 24-month period on the first day of each month. There is a termination right six weeks before the end of the month as per the terms of the contract. Further information on termination options is included in the contract documents. AOK Rheinland-Pfalz/Saarland - The…

TENDER BRIEF

TENDER DOCUMENTS